Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO) 19-02-2025, 04:30

Slalom Comes To New Zealand With New Office in Auckland 8-02-2023, 04:30

Samsung Takes Top Spot in U.S. Patents for Third Year Running while TSMC Rises into Second Place; After Four-Year Falloff, Grants Increase Nearly 4% 14-01-2025, 16:00